Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination
Clinical trial NCT06862739 · RECRUITING
Trial details
- NCT number
- NCT06862739
- Sponsor
- Nabiqasim Industries (Pvt) Ltd
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-30
- Primary completion
- 2026-04-30
- Enrollment
- 800
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.